Hikma Pharmaceuticals has committed $267 million to expand two manufacturing sites in Ohio, adding 350 jobs, as part of its broader $1 billion U.S. investment plan. For overseas buyers of sterile injectables and oral solid dose products, this signals increased production capacity and potential supply chain stability from a major global player.
Investment breakdown
Hikma will spend $216 million at its Columbus facility to boost oral solid dose and nasal inhalation production, creating 50 jobs. The site, operating since 1938, is one of Columbus's largest manufacturing employers and also houses one of Hikma's three global R&D hubs. The remaining $51 million will go to the Bedford site for injectables expansion, including new aseptic vial filling and lyophilization technology, adding 300 positions.
Strategic context
The expansion follows Hikma's June 2025 announcement of $1 billion in U.S. investments by 2030. The company has invested over $4 billion in the U.S. over the past 15 years. Ohio tax officials have approved certain credits to support the projects, with additional state and local incentives pending.
What buyers should watch
For importers and distributors of sterile injectables, Hikma's increased aseptic filling and lyophilization capacity in Bedford could mean more reliable supply of high-quality injectable drugs. The Columbus expansion may also enhance availability of oral solid dose and nasal inhalation products. Buyers should monitor production timelines and potential new product launches from these expanded facilities.
Regulatory and channel signals
Ohio Governor Mike DeWine highlighted that the investment "strengthens its ability to ensure patients have reliable access to the medicines they need" and "signals to the industry that Ohio will continue to be a major player in the future of healthcare." This state-level support may encourage other pharmaceutical manufacturers to expand in the region, potentially creating a more robust supply chain hub for medical aesthetics and pharmaceutical products.
Source: Read the original report | Published: June 08, 2026